[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO970185L - Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi - Google Patents

Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi

Info

Publication number
NO970185L
NO970185L NO970185A NO970185A NO970185L NO 970185 L NO970185 L NO 970185L NO 970185 A NO970185 A NO 970185A NO 970185 A NO970185 A NO 970185A NO 970185 L NO970185 L NO 970185L
Authority
NO
Norway
Prior art keywords
treatment
same
reperfusion injury
adenosyl
methionine
Prior art date
Application number
NO970185A
Other languages
English (en)
Other versions
NO970185D0 (no
Inventor
Laszlo Szabo
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO970185D0 publication Critical patent/NO970185D0/no
Publication of NO970185L publication Critical patent/NO970185L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Anvendelsen av (SAMe) og dets fysiologisk akseptable salter til behandling av reperfusjonsskader som utløses av temporær fokal ischemi, beskrives.
NO970185A 1994-07-16 1997-01-15 Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi NO970185L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4425280A DE4425280C2 (de) 1994-07-16 1994-07-16 Verwendung von (S)-Adenosyl-L-methionin und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die nach temporärer fokaler Ischämie ausgelöst werden
PCT/EP1995/002598 WO1996002252A1 (de) 1994-07-16 1995-07-05 VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe) UND DESSEN PHYSIOLOGISCH VERTRÄGLICHEN SALZEN ZUR BEHANDLUNG VON REPERFUSIONSSCHÄDEN, DIE DURCH TEMPORÄRE FOKALE ISCHÄMIE AUSGELÖST WERDEN

Publications (2)

Publication Number Publication Date
NO970185D0 NO970185D0 (no) 1997-01-15
NO970185L true NO970185L (no) 1997-03-12

Family

ID=6523426

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970185A NO970185L (no) 1994-07-16 1997-01-15 Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi

Country Status (18)

Country Link
US (1) US5776911A (no)
EP (1) EP0771202A1 (no)
JP (1) JPH10502652A (no)
KR (1) KR970704442A (no)
AU (1) AU2927195A (no)
BG (1) BG101145A (no)
CA (1) CA2195345A1 (no)
CZ (1) CZ12297A3 (no)
DE (1) DE4425280C2 (no)
FI (1) FI970165A (no)
HR (1) HRP950405A2 (no)
HU (1) HUT76834A (no)
IL (1) IL114540A0 (no)
NO (1) NO970185L (no)
PL (1) PL318318A1 (no)
SI (1) SI9520087A (no)
WO (1) WO1996002252A1 (no)
ZA (1) ZA955865B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
IT1317920B1 (it) * 2000-10-20 2003-07-15 Univ Roma S-adenosilmetionina e suoi derivati per il trattamento e laprevenzione della malattia di alzheimer.
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
WO2006111541A2 (en) * 2005-04-20 2006-10-26 Basf Plant Science Gmbh Expression cassettes for seed-preferential expression in plants
WO2009114939A1 (en) 2008-03-17 2009-09-24 National Research Council Of Canada Aromatic prenyltransferase from hop

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
JPH0770235B2 (ja) * 1988-06-24 1995-07-31 株式会社東芝 不揮発性メモリ回路装置
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体

Also Published As

Publication number Publication date
US5776911A (en) 1998-07-07
MX9700439A (es) 1998-05-31
WO1996002252A1 (de) 1996-02-01
PL318318A1 (en) 1997-06-09
NO970185D0 (no) 1997-01-15
JPH10502652A (ja) 1998-03-10
SI9520087A (en) 1997-08-31
CZ12297A3 (cs) 1998-04-15
HRP950405A2 (en) 1997-10-31
DE4425280A1 (de) 1996-01-18
KR970704442A (ko) 1997-09-06
CA2195345A1 (en) 1996-02-01
IL114540A0 (en) 1995-11-27
FI970165A0 (fi) 1997-01-15
BG101145A (en) 1997-08-29
AU2927195A (en) 1996-02-16
HU9700130D0 (en) 1997-02-28
ZA955865B (en) 1997-01-14
DE4425280C2 (de) 1997-05-07
FI970165A (fi) 1997-03-14
HUT76834A (en) 1997-11-28
EP0771202A1 (de) 1997-05-07

Similar Documents

Publication Publication Date Title
NO911694D0 (no) Mikroemulsjonsblanding til haarbehandling, fremgangsmaate for fremstilling og anvendelse derav.
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
DK1059934T3 (da) Matrixproteinpræparater til sårheling
AU1798995A (en) Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin
DK261490D0 (da) New pharmaceutical compound
HUP9904109A2 (hu) Külsőleg használandó helyi érzéstelenítő
SE9701161D0 (sv) New use I
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
NO922385D0 (no) Mykt toerrfor, saerlig til bruk som avvenningsfor, og fremgangsmaate til fremstilling derav
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
BG101126A (en) The use of muramylpeptide compounds
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
SE8603481L (sv) Topisk stralskyddsgel for mukosa
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ES2152315T3 (es) Xamoneline tartrato.
SE9604752D0 (sv) Formulation and use
DK0663832T3 (da) Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
KR970019821A (ko) 송진을 함유한 치약 제조 방법